Events and Media

Oncocyte in the Media

02/05/2020Oncocyte closes acquisition of Insight GeneticsS&P Global
01/24/2020OncoCyte Launches NSCLC Stratification Test, Looks beyond Lung CancerGenEDGE
10/08/2019Oncocyte Eyeing More Tuck-ins As It Grows Cancer Diagnostic PortfolioMergermarket
10/01/2019Transitioning Emerging Companies into Commercial PowerhousesPharmaVOICE
09/24/2019Oncocyte Acquires Razor Genomics to Improve Management of Early-Stage Lung CancerBioSpace
09/09/2019 Oncocyte Resurrecting Lung Cancer Assay Once Marketed by Life TechnologiesGenomeWeb
09/05/2019Oncocyte Spells Out the Acquisition Plan for Razor GenomicsMD+DI
09/05/2019Oncocyte to Buy Early Lung Cancer Testing Company Razor GenomicsClinical OMICs
06/11/2019Oncocyte to be Added to the Russell 2000®, 3000® and Microcap IndexesMarkets Insider
06/06/2019Oncocyte (OCX) Announces Ronald Andrews will assume Role of CEOStreet Insider
05/29/2019Oncocyte Strengthens Senior Management Team With Two New HiresGlobe Newswire
05/21/2019 Oncocyte (OCX) Presents Positive Results from R&D Validation Study of DetermaVu at ATSStreet Insider
02/13/2019Piper Jaffray Starts Oncocyte Corp (OCX) at OverweightStreet Insider
02/12/2019Oncocyte Announces Closing of Public Offering of Common Stock Globe Newswire
01/30/2019Oncocyte Readies Lung Cancer Test for Launch, Previews New Platform Validation DataGenomeWeb
01/29/2019Oncocyte upgraded to buy at Janney on high hopes for lung cancer biopsy testMarketWatch
01/03/2019Oncocyte Announces Transition to Ion Torrent Next-Generation Sequencing PlatformGlobe Newswire